학술논문

Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19.
Document Type
Article
Source
Science Translational Medicine; 9/22/2021, Vol. 13 Issue 612, p1-18, 18p
Subject
COVID-19
AUTOANTIBODIES
TYPE I interferons
MONONUCLEAR leukocytes
MYELOID cells
COVID-19 pandemic
CELL populations
Language
ISSN
19466234
Abstract
Copyright of Science Translational Medicine is the property of American Association for the Advancement of Science and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)